Printer Friendly

COMPANY INFORMATION
Medicure Inc. 2-1250 Waverley St Winnipeg, MB R3T 6C6 Tel: (204) 487-7412 Toll-free: (888) 435-2220 Fax: (204) 488-9823 Contact Name Adam Peeler Industry Biotechnology		Key Executives Albert D. Friesen, CEO Eric R. Johnstone, CFO Holds U.S. rights to acute coronary syndrome treatment AGGRASTAT® Injection. Also researches and develops small molecule compounds to treat neurological and cardiovascular disorders.
FP ADVISOR COVERAGE Medicure Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Investor Reports • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Biotechnology Company Name Revenue ($000s)  Atrium Innovations Inc. 309,546 Angiotech Pharmaceuticals, Inc. 302,251 QLT Inc. 132,457 Oncothyreon Inc. 42,678 AEterna Zentaris Inc. 41,056 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/MPH $0.02 $0.08 $0.02 n.a. n.a. n.a. 0.61 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 201,130 n.a. $-0.04 Nov. 30/09 -42.86% -74.93% -52.76% $2,606
ANNUAL FINANCIALS Periods ended: 12m May 31/09 12m May 31/08 12m May 31/07 $000s $000s $000s Operating revenue 4,793 2,247 5,945 Net income (13,316) (57,403) (31,703) Total assets 9,550 34,805 59,786 $ $ $ Earnings per share* (0.10) (0.46) (0.30) % % % Return on equity n.m. n.m. (88.71)   * Common vtg.
TRAILING 12-MONTH VALUES Periods ended: Nov. 30/09 Nov. 30/08 $000s $000s Operating revenue 4,082 4,073 Net income (5,419) (35,364) $ $ Earnings per share (0.04) (0.26)

COMPANY NEWS

Results for 'Medicure Inc.' from past 30 days: No hits. (Links are to articles.)